Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis.
about
The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus.Cost-effectiveness of insulin detemir: a systematic review.Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer's perspective.Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus.Economic analysis of insulin initiation by pharmacists in a Canadian setting: The RxING study.A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens.
P2860
Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Modeling the lifetime costs of ...... a cost-minimization analysis.
@en
Modeling the lifetime costs of ...... a cost-minimization analysis.
@nl
type
label
Modeling the lifetime costs of ...... a cost-minimization analysis.
@en
Modeling the lifetime costs of ...... a cost-minimization analysis.
@nl
prefLabel
Modeling the lifetime costs of ...... a cost-minimization analysis.
@en
Modeling the lifetime costs of ...... a cost-minimization analysis.
@nl
P2093
P921
P1476
Modeling the lifetime costs of ...... a cost-minimization analysis.
@en
P2093
Anne-Laure Guillermin
Donna Wright
Julie Villeneuve
Tini Nguyen
P304
P356
10.3111/13696998.2011.561390
P407
P577
2011-03-02T00:00:00Z